U.S. markets close in 3 hours 7 minutes
  • S&P 500

    4,586.25
    +53.49 (+1.18%)
     
  • Dow 30

    35,373.61
    +344.96 (+0.98%)
     
  • Nasdaq

    14,569.46
    +229.21 (+1.60%)
     
  • Russell 2000

    2,098.03
    +35.25 (+1.71%)
     
  • Crude Oil

    87.25
    +0.29 (+0.33%)
     
  • Gold

    1,842.90
    -0.30 (-0.02%)
     
  • Silver

    24.73
    +0.50 (+2.06%)
     
  • EUR/USD

    1.1333
    -0.0014 (-0.12%)
     
  • 10-Yr Bond

    1.8330
    +0.0060 (+0.33%)
     
  • GBP/USD

    1.3631
    +0.0019 (+0.14%)
     
  • USD/JPY

    114.1190
    -0.2340 (-0.20%)
     
  • BTC-USD

    43,095.02
    +934.98 (+2.22%)
     
  • CMC Crypto 200

    1,024.88
    +29.62 (+2.98%)
     
  • FTSE 100

    7,585.01
    -4.65 (-0.06%)
     
  • Nikkei 225

    27,772.93
    +305.70 (+1.11%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HYRE, SPPI and NNOX

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / October 26, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

HyreCar Inc. (NASDAQ:HYRE)
Class Period: May 14, 2021 - August 10, 2021
Lead Plaintiff Deadline: October 26, 2021

The HYRE lawsuit alleges HyreCar Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) HyreCar had materially understated its insurance reserves; (b) HyreCar had systematically failed to pay valid insurance claims incurred prior to the Class Period; (c) HyreCar had incurred significant expenses transitioning to its new third-party insurance claims administrator and processing claims incurred from prior periods; (d) HyreCar had failed to appropriately price risk in its insurance products and was experiencing elevated claims incidence as a result; (e) HyreCar had been forced to dramatically reform its claims underwriting, policies and procedures in response to unacceptably high claims severity and customer complaints; and (f) as a result, HyreCar's operations and prospects were misrepresented because the Company was not on track to meet the financial estimates provided to investors during the Class Period, and such estimates lacked a reasonable basis in fact, including HyreCar's purported gross margin, EBITDA (earnings before interest, taxes, depreciation, and amortization), and net loss trajectories.

Learn about your recoverable losses in HYRE: https://www.kleinstocklaw.com/pslra-1/hyrecar-inc-loss-submission-form?id=20666&from=1

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)
Class Period: December 27, 2018 - August 5, 2021
Lead Plaintiff Deadline: November 1, 2021

According to the complaint, Spectrum Pharmaceuticals, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SPPI: https://www.kleinstocklaw.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?id=20666&from=1

Nano-X Imaging Ltd. (NASDAQ:NNOX)
Class Period: June 17, 2021 - August 18, 2021
Lead Plaintiff Deadline: December 6, 2021

During the class period, Nano-X Imaging Ltd. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Nano-X's 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC's regulatory and commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in NNOX: https://www.kleinstocklaw.com/pslra-1/nano-x-imaging-ltd-loss-submission-form-2?id=20666&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/669664/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-HYRE-SPPI-and-NNOX